Navigation Links
Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
Date:10/22/2010

BELGRADE, Mont., Oct. 22 /PRNewswire/ -- Bacterin International Holdings, Inc. (OTC Bulletin Board: BIHI) ("Bacterin"), today announced that it is scheduled to present at the upcoming Singular Research 5th Annual Best of the Uncovereds conference on Thursday, November 4, 2010 at 3:20p.m.(PT) at the Luxe Hotel Sunset Boulevard, Los Angeles, California.

Guy Cook, Founder & CEO of Bacterin, and John Gandolfo, Bacterin's chief financial officer, will review and provide an update on the Company's progress.  Bacterin, founded in 1998 as a spin out from the National Science Foundation's Center for Biofilm Engineering, is a developer of unique, anti-infective coatings for medical applications and a producer of revolutionary scaffolds for tissue regeneration.  

About Bacterin International Holdings, Inc.

Bacterin International Holdings, Inc. ("Bacterin") develops, manufactures and markets biologics products to domestic and international markets.  Bacterin's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth.  These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain by facet joint stabilization, promotion of bone fusion in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral bone defect repair in articulating joint surgeries.

Bacterin's Medical Device division develops anti-microbial coatings based upon proprietary coating technologies. Bacterin develops, employs, and licenses bioactive coatings for various medical device applications.  Bacterin's strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination on medical devices drug delivery, local (as opposed to systemic) pain management, and anti-thrombotic factors for medical device applications.  

Headquartered in Belgrade, Montana, Bacterin operates a 32,000 square foot, state-of-the-art, fully compliant and FDA registered facility, equipped with four "Class 100" clean rooms.  For further information please visit www.bacterin.com.

About Singular Research

Singular Research aims to be the most trusted supplier of independent research on small-cap companies.

* Our analysts research companies generally that are not covered by any other firms.

* We provide Honest Advice: Our Independent analysts have no financial interest in the stocks we cover. Analysts are compensated based on the accuracy of their research calls not through trading commissions or investment banking fees.

* Track Record: Our coverage list compounded annual performance since inception is 13.04% vs. 3.45% for the Russell 2000, from August 2004 through September 2010. Performance YTD in 2010 is 8.9% vs. 7.4% for the Russell 2000.

http://www.singular-research.com/discover/broadcast-news.htm

This press release contains certain "forward-looking statements" as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors are detailed from time to time in Bacterin's filings with the United States Securities and Exchange Commission and other regulatory authorities.


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
2. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
3. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
4. Bacterin International Introduces OsteoSelect(R) DBM Putty
5. Bacterin International Completes $3 Million Private Placement
6. Rhythmlink International Announces Change in Engineering Management
7. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
8. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
9. Dehaier Medical Shows New Products at 2010 China International Medical Equipment Fair
10. Beaver-Visitec International to Focus on Ophthalmic and Microsurgery Products and Services
11. Sixth U.S. Patent Issued to Dyadic International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... , Aug. 15, 2017 Diplomat Pharmacy, ... to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher Road. ... by the Food and Drug Administration, is intended to ... drowsiness, slowed breathing, and loss of consciousness. The medication ...
(Date:8/11/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it will release its ... host a conference call at 9:00am ET. The Company ... results and its strategy and outlook for the remainder ... Erez Raphael , Chief Executive Officer, and Zvi ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... In a recent survey, eighty-two ... diet and exercise. In fact, cellulite can't always be eliminated by diet and exercise ... treatment available to select physicians nationwide. Dr. Kenneth Rothaus has recently added Cellulaze™ ...
(Date:8/16/2017)... ... 2017 , ... The Southeastern Telehealth Resource Center at the ... its funding from the Health Resources and Services Administration (HRSA), part of the ... time the HRSA administration has renewed its financial support to GPT since 2010 ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD diagnosis every ... cure. , The grants are awarded through a competitive application process and reviewed ... array of backgrounds and expertise in all areas relevant to PD research. The ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... based in Vero Beach, announced today that two of their associates were recognized ... represents professionally managed senior living communities in Florida. The awards were announced at ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... announces their latest new client win in the healthcare market, with Los Angeles-based ... to support healthcare staff and members. , AHF cares for nearly 800,000 individuals ...
Breaking Medicine News(10 mins):